• Trade with Confidence
    • CanninBot™
    • CanninPlus™
  • Investor Resources
    • News
    • Featured Companies
  • About
  • Login
0 Items
Cannin. com - Cannabis Stock Investing
  • Trade with Confidence
    • CanninBot™
    • CanninPlus™
  • Investor Resources
    • News
    • Featured Companies
  • About
Select Page
400% Revenue Increase for Heritage Cannabis in Q1 2022

400% Revenue Increase for Heritage Cannabis in Q1 2022

Cannabis in the News, Financial Results

400% Revenue Increase for Heritage Cannabis in Q1 2022 Heritage Cannabis Holdings Corp. (CSE: CANN) (OTCQX: HERTF), today announced its financial results as at and for the three months ended January 31, 2022 (“Q1 2022”). All figures are in Canadian dollars unless...
Got Dividends? Altria Announces $0.90/share this Quarter

Got Dividends? Altria Announces $0.90/share this Quarter

Cannabis in the News, Financial Results

Got Dividends? Altria Announces $0.90/share this Quarter Altria Group, Inc. (NYSE: MO) held its 2022 Annual Meeting of Shareholders (Annual Meeting) today. During the Annual Meeting, Billy Gifford, Altria’s Chief Executive Officer, summarized our full-year 2021 and...
Cresco reports 20% year-over-year revenue growth

Cresco reports 20% year-over-year revenue growth

Cannabis in the News, Cresco, Financial Results

Cresco reports 20% year-over-year revenue growth Cresco reports 20% year-over-year revenue growth and 45% year-over-year adjusted EBITDA1 growth – and continues industry leadership in branded wholesale and retail productivity Clears first milestone in proposed...
SNDL Q1 2022 Net Loss Narrows, Revenue Rises

SNDL Q1 2022 Net Loss Narrows, Revenue Rises

Cannabis in the News, Financial Results, Stock Talk

SNDL Q1 2022 Net Loss Narrows, Revenue Rises Sundial Growers (SNDL) reports a narrower Q1 net loss late Monday of $0.02 ($0.02) per diluted share, compared with CA$0.09 a year earlier. However, SNDL revenue for the quarter ended March 31 was CA$17.6 million ($13.7...
MediPharm Labs Reports Financials for Q1 2022

MediPharm Labs Reports Financials for Q1 2022

Cannabis in the News, Financial Results

MediPharm Labs Reports Financials for Q1 2022 MediPharm Labs Corp.(OTCQX: MEDIF) a pharmaceutical company specialized in precision-based cannabinoids, today announced its financial results for the three months ended March 31, 2022. Q1 2022 – Select Operating...
Columbia Care Reports Q2 2022 Financial Results

Columbia Care Reports Q2 2022 Financial Results

Cannabis in the News, Financial Results

Columbia Care Reports Q2 2022 Financial Results Quarterly Revenue of $123 Million, an Increase of 43% YoY Gross Profit of $57 Million, an Increase of 68% YoY Gross Margin of 46%, an Increase of 676bps YoY, 149bps QoQ Over Prior Adjusted Gross Margin1 Adjusted EBITDA...
« Older Entries
Next Entries »

Search Cannabis and Hemp Stocks

Turn 10 into 17625 in 1 day

Free Expert Stock Tips

* indicates required

Try CanninBot with Algo Trading Alerts FREE!

Get advance notice of profitable cannabis & hemp stock trades. Use our machine learning algorithm to start profiting from this explosive industry.

GET A FREE TRIAL

$29 / month after 7-day trial. Still unsure? Schedule demo at demo@cannin.com or call 720-254-1374

Recent Posts

  • Cannabis Use Linked to Increased Sexual Satisfaction February 3, 2023
  • USDA issues first National Hemp Report January 30, 2023
  • Top 3 Benefits to Cannabis Legalization January 30, 2023
  • Village Farms (VFF) Becomes Canada’s Leading Cannabis Producer January 30, 2023
  • IIPR Announces Operating, Investment and Capital Markets Activity January 30, 2023

Search for Specific Hemp and Cannabis Stocks

From the Cannin Community

"Cannin sends specific instructions on how to make the trade. They continue to send profitable signals and I love their service. Thanks, Cannin!"

-Mark H.
Vail, Colorado

Turn 10 into 17625 in 1 day

Free Expert Stock Tips

* indicates required

Try CanninBot with Algo Trading Alerts FREE!

Get advance notice of profitable cannabis & hemp stock trades. Use our machine learning algorithm to start profiting from this explosive industry.

GET A FREE TRIAL

$29 / month after 7-day trial. Still unsure? Schedule demo at demo@cannin.com or call 720-254-1374

Risk of Prosecution for Marijuana-Related Companies.  If you are considering investing in a company that is connected to the marijuana industry, be aware that marijuana-related companies may be at risk of federal, and perhaps state, criminal prosecution.  The Department of Treasury recently issued guidance noting: “ The Controlled Substances Act (“CSA”) makes it illegal under federal law to manufacture, distribute, or dispense marijuana.  Many states impose and enforce similar prohibitions.  Notwithstanding the federal ban, as of the date of this guidance, 20 states and the District of Columbia have legalized certain marijuana-related activity.”

  • Facebook
  • Twitter
  • Instagram
© 2020 Cannin All Rights Reserved. | Refund | Terms | Privacy | Cannin.com 3000 Lawrence Street #6 Denver, Colorado 80205